Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.
Purity:
>99.0%
CAS Number:
[1610833-03-8]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted